Here’s how to overcome the hurdles that hinder your population health strategies.
Modern Medicine Feature Articles
FDA’s approval of the first generic version of Copaxone for treating patients with relapsing forms of multiple sclerosis has industry insiders contemplating the impact on the generics market as well as payer coverage strategies.
More than 750 government and private ACOs are now in place, helping healthcare transition away from fee-for-service. Find out what's working and what's planned for the future.
Consensus is building on the promise of genetic testing and other technological advances to help individualize testing, prevention and treatment for better outcomes.
Consumers searching for health information on Google will now see results from Mayo Clinic in a feature box at the top of the return screen.
Research has been given a shot in the arm by Apple Corp, which recently expanded the use of ResearchKit to include clinical trials.
The number of deaths from prescription pain relievers dropped 5% in 2012, and new tools are helping in the fight against opioid abuse.
Hospital rankings provide consumers with valuable information, but they're not always in agreement.
After several years of uneven progress, the pace of healthcare payment reform shifted into high gear in January when the U.S Department of Health and Human Services (HHS) announced plans to tie 30% of traditional, or fee-for-service, Medicare payments to quality or value alternative payment models by the end of 2016, and 50% by the end of 2018.
Blue Cross Blue Shield of Massachusetts has taken big steps to curb the growing opioid addiction problem.